Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules
- PMID: 15144951
- DOI: 10.1016/s1535-6108(04)00115-1
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules
Abstract
Through a poorly understood mechanism, tumors respond to radiation by secreting cytokines capable of inhibiting apoptosis in endothelial cells, thereby diminishing treatment response by minimizing vascular damage. We reveal here that this pathway is governed by a major angiogenesis regulator, HIF-1. Following radiotherapy, tumor reoxygenation leads to: (1) nuclear accumulation of HIF-1 in response to reactive oxygen, and (2) enhanced translation of HIF-1-regulated transcripts secondary to stress granule depolymerization. The resulting increase in HIF-1-regulated cytokines enhances endothelial cell radioresistance. Inhibiting postradiation HIF-1 activation significantly increases tumor radiosensitivity as a result of enhanced vascular destruction. These data describe novel pathways contributing significantly to our understanding of HIF-1 regulation which may be major determinants of tumor radiosensitivity, potentially having high clinical relevance.
Comment in
-
Intratumoral hypoxia, radiation resistance, and HIF-1.Cancer Cell. 2004 May;5(5):405-6. doi: 10.1016/s1535-6108(04)00118-7. Cancer Cell. 2004. PMID: 15144945
Similar articles
-
Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.Cancer Cell. 2005 Aug;8(2):99-110. doi: 10.1016/j.ccr.2005.06.016. Cancer Cell. 2005. PMID: 16098463
-
Raising the bar: how HIF-1 helps determine tumor radiosensitivity.Cell Cycle. 2004 Sep;3(9):1107-10. Epub 2004 Sep 20. Cell Cycle. 2004. PMID: 15326390 Review.
-
Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.Cancer Res. 2000 Aug 1;60(15):4066-9. Cancer Res. 2000. PMID: 10945611
-
Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation.Cancer Res. 2005 Jul 1;65(13):5498-505. doi: 10.1158/0008-5472.CAN-04-4553. Cancer Res. 2005. PMID: 15994919
-
Regulation of angiogenesis by hypoxia: role of the HIF system.Nat Med. 2003 Jun;9(6):677-84. doi: 10.1038/nm0603-677. Nat Med. 2003. PMID: 12778166 Review.
Cited by
-
Understanding the roles of stress granule during chemotherapy for patients with malignant tumors.Am J Cancer Res. 2020 Aug 1;10(8):2226-2241. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905441 Free PMC article. Review.
-
Microenvironmental regulation of therapeutic response in cancer.Trends Cell Biol. 2015 Apr;25(4):198-213. doi: 10.1016/j.tcb.2014.11.006. Epub 2014 Dec 22. Trends Cell Biol. 2015. PMID: 25540894 Free PMC article. Review.
-
The interaction of anticancer therapies with tumor-associated macrophages.J Exp Med. 2015 Apr 6;212(4):435-45. doi: 10.1084/jem.20150295. Epub 2015 Mar 9. J Exp Med. 2015. PMID: 25753580 Free PMC article. Review.
-
The roles of hypoxia-inducible factors in regulating neural stem cells migration to glioma stem cells and determinating their fates.Neurochem Res. 2012 Dec;37(12):2659-66. doi: 10.1007/s11064-012-0879-x. Epub 2012 Sep 19. Neurochem Res. 2012. PMID: 22991140 Review.
-
Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview.Cancers (Basel). 2021 May 15;13(10):2394. doi: 10.3390/cancers13102394. Cancers (Basel). 2021. PMID: 34063424 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical